Saltar al contenido
  • Home
  • About Us
  • Our Science
    • TCR-like platform
    • Lent-On-Plus Platform
  • Our Collaborators
  • News
  • Contact
  • Home
  • About Us
  • Our Science
    • TCR-like platform
    • Lent-On-Plus Platform
  • Our Collaborators
  • News
  • Contact

© 2019

PRECISION GENE THERAPY FOR CANCER IMMUNOTHERAPY

TOWARDS TO A SAFER AND MORE EFFICIENT ADVANCE THERAPIES

by Carlos Martín
on diciembre 2, 2021

Our Manager of R&D Pedro Justicia presents LentiStem during the «Open Innovation Forum in Biomedical Research» organized by GENyO Research Center

Categories:

Sin categoría

Tags:

Sin etiqueta

Navegación de entradas

Previous post Presentation for San Telmo Business School

Navegación de entradas

Next post Participation in Genyo Scientist Conference

Comments are closed

Entradas recientes
  • LentiStem en Transfiere 2024 Málaga presenta el proyecto FITHER18 para el tratamiento de tumores sólidos HER2+
  • LentiStem Biotech to Present our CAR-T Therapy Project at European Conference on Personalised Medicine
  • LentiStem Biotech is awarded an Industrial PhD grant from Spain’s Ministry of Science and Innovation
  • SETGyC 11th Biennial Congress – Seville
  • Road to Boston
Comentarios recientes
    © 2025 Lentistem Biotech. Created for free using WordPress and Colibri